Background and Aims -Dengue is a systemic viral infection, which is caused by any of the four strains of dengue virus and is transmitted between humans by the bite of Aides aegypti mosquito. Hepatic dysfunction is common in dengue infection with varying degree according to the severity of the disease. The aim of this study was to analyze the spectrum of liver involvement in dengue infection during a major outbreak that occurred in central Nepal between September and December 2010.
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IntroductIon
Dengue is one of the most important arboviral infections of humans. 1 The disease is caused by four antigenically distinct but related dengue viruses (DENV 1-4) and is transmitted primarily by Aedes aegypti mosquito. The global incidence of DF and DHF has increased dramatically in recent decades. 1, 2 Dengue virus is now the most common cause of arboviral disease in the world, with an estimated annual occurrence of 100 million cases of DF and 250 000 cases of DHF with a mortality rate of 25 000 per year. 3 The spectrum of Dengue infection has been conventionally divided into Dengue Fever (DF), Dengue Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS). Unusual manifestations involving liver and central nervous system in dengue infection have been reported. 4, 5 Hepatic dysfunction is a well-recognized feature of dengue infections, often demonstrated by hepatomegaly and mild-to moderate increases in transaminase levels although jaundice and acute liver failure are generally less common. 6, 7 However, there are few case reports of fulminant hepatic failure in DHF. 8, 9 The incidence of hepatic dysfunction is more in DHF than in DF. 4 This study aims at analyzing the spectrum of liver involvement between DF and DHF using the results obtained during a major dengue outbreak in Nepal.
Methods
A major dengue outbreak occurred in Chitwan district and surrounding areas between September and December, 2010. A prospective study was conducted to describe the spectrum of symptomatic dengue disease among adults admitted to the department of medicine at Chitwan Medical College. During this time, patients with a history of fever in the ten preceding days (acute febrile illness) and no clinical evidence of bacterial infection anywhere in the body were examined and had at least one blood sample collected for specific dengue and other laboratory tests. Among the 1456 patients tested for dengue serology, 426 tested positive for the disease of which 414 cases were included in the study as rest of the patients (n=12) had other concomitant conditions like viral hepatitis, malaria and leptospirosis.
The definition of DHF included fever, thrombocytopenia (platelet count less than 100 000 per mm 3 ), hemorrhagic manifestations, and objective evidence of plasma leakage revealed by more than 20% rise in hematocrit over baseline or more than 20% drop in hematocrit after treatment or presence of plasma leakage signs such as pleural effusion, ascites and hypoproteinemia. 1 For the diagnosis of dengue shock syndrome (DSS), the presence of hypotension or narrow pulse pressure was required in addition to the previously mentioned criteria. Any subject with serological evidence of acute dengue infection who did not meet the criteria for DHF or DSS was considered as having DF.
After written informed consent, demographic and personal details of the patients were recorded. Clinical data were collected through interviews with patients or their attendants. Detailed clinical information were recorded with special focus on the duration and intensity of fever, as well as associated symptoms like headache, nausea, vomiting, anorexia, body ache and bleeding diathesis. A meticulous physical examination of the patients was conducted. Hepatomegaly and ascites were ascertained by physical examination and on reports of ultrasonography and X-rays. 
results
More than two third of the patients came from Chitwan district (70.4%) followed by Nawalparasi (18.8%) and Rupandehi districts (6.0%). Table 1 shows the district-wise distribution of dengue patients by their place of residence. A majority of the patients (84.6%) were in the age group 16-60 years, which is considered to be the most productive part of one's life (Figure 1 ).Total number of male and female patients was 242 and 172 respectively with the Male: Female ratio of 1: 0.7. Table 2 . Following the existing WHO criteria, 79.3% (n=329) of the patients were diagnosed with classic DF and 20.5% (n=85) with DHF. Three of them had clinically significant bleeding. One of the two patients diagnosed with DSS had co-morbidities of post-TB bronchiectasis and alcoholic liver disease and died during the course of the treatment in the ICU. One of the patients was admitted with features of fulminant hepatic failure with altered sensorium, deep jaundice and deranged transaminase level (AST of 14 100 IU and ALT of 5760 IU). However, this patient survived and AST and ALT values returned to 105 IU and 120 IU respectively on the eleventh day of illness. All three measures of platelet counts, elevated ALT and elevated AST were significantly higher in DHF as compared to patients with DF. The results from ultrasound of the abdomen including hepatomagaly, thickened gall bladder and third space loss are presented in The dengue outbreak started between end-August and early September and peaked by late October. Dengue-specific IgM was positive in 69% of patients, which is comparable to other studies. 11, 12 According to WHO criteria for diagnosis, 329 (79.3%) of the patients were diagnosed as classic DF, 83 (20.5%) as DHF, with additional two DSS cases.
Hepatic involvement in dengue infections is often demonstrated by hepatomegaly and mild-to-moderate increases in transaminase levels. Clinical evidence included hepatomegaly and increased serum liver enzymes, with liver involvement being more pronounced in the more severe forms of infection. Out of 414 cases, 39.1% had hepatomegaly. The difference in hepatomegaly among DF and DHF was significant (p<.0001) which was more common in DHF (72.9%) than in DF (30.4%). In one study done in India, 79% of the patients had hepatomegaly. 17 Another study done in Vietnam revealed hepatomegaly in 96% of Dengue patients and also showed significant differences in hepatic changes among those with and without shock. 18 In dengue infections, elevations in serum AST appear to be greater than ALT levels. This differs from the pattern in viral hepatitis, in which ALT levels are usually higher than or equal to AST levels. 13 The causes from these indications are still uncertain. It has been suggested that it may be due to excess release of AST from damaged myocytes during dengue infections. 14 The elevated AST levels tend to return to normal more rapidly than ALT levels. This is possibly because AST (12.5-22 h) has a shorter half-life than ALT (32-43 h).
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In the study, liver enzyme AST was increased with the value more than 50 IU/ml in 78.4% and 96.5% of cases of DF and DHF respectively. Similarly, ALT value was raised in 53.8% of DF and 74.1% of DHF patients. The difference in the rise of liver enzymes in DHF and DF was statistically significant (P<0.001).
Various studies in the past reported liver dysfunction to be more common in DHF than in DF patients.
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The dengue virus is able to replicate in both hepatocytes and Kupffer cells. 16 Mechanisms of liver injury in dengue may be due to direct effects of the virus or host immune response on liver cells, circulatory compromise, metabolic acidosis and/or hypoxia caused by hypotension or localized vascular leakage inside the liver.
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Detection of abnormally high transaminase enzymes among patients with dengue is important since the possibility of consequent hepatic encephalopathy can be expected. 4 Liver dysfunction was mild to moderate in most of the patients in the study, presenting primarily as elevation of serum aminotransferases. However, some patients had clinical manifestations of liver disease, namely jaundice, hepatomegaly and ascites. One of the patients with DSS had findings consistent with acute liver failure with AST and ALT level of 14100 IU and 5760 IU respectively. However, the patient survived and had near normal aminotransferase level at the time of discharge, which had come down to normal in follow up after one month.
The most common ultrasound findings were hepatomegaly, third space loss in the form of ascites and pleural effusion and thickened gall-bladder. DHF had significantly higher prevalence of these conditions then DF. Similar findings in ultrasound abdomen were reported in different studies. 20, 21 conclusIon Dengue, which was considered a rare disease entity in Nepalese context, is not a strange disease. The spectrum of liver involvement in dengue varied as per the severity of dengue infection. The study findings suggest that presence of fever, jaundice and hepatomegaly in endemic areas should arouse the suspicion of hepatitis associated with dengue infection.
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